Home / Publication / Pharmacodynamic Analysis of Eribulin Safety in Breast Cancer Patients Using Real-world Postmarketing Surveillance Data

論文

Pharmacodynamic Analysis of Eribulin Safety in Breast Cancer Patients Using Real-world Postmarketing Surveillance Data

Author(s): Takahisa Kawamura, Hidefumi Kasai, Valentina Fermanelli, Toshiaki Takahashi, Yukinori Sakata, Toshiyuki Matsuoka, Mika Ishii, Yusuke Tanigawara

Year: 2018年6月22日

Pharmacodynamic Analysis of Eribulin Safety in Breast Cancer Patients Using Real-world Postmarketing Surveillance Data

Pharmacodynamic Analysis of Eribulin Safety in Breast Cancer Patients Using Real-world Postmarketing Surveillance Data

トランスレーショナル開発における中和ADA効果の薬物動態モデリング

Extrapolating AUC to Infinity

AUC（線形および対数線形）の計算

Accumulation: What It Means and How to Calculate It

メルマガ登録

クイックアクセス

ソリューション

お問合せ